Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulindac vs Placebo after Metastasectomy in Stage IV Colorectal Cancer
NCT01856322Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Apr 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sulindac in colorectal cancer (CRC), sponsored by National Cancer Institute. Started Apr 2013; status: terminated.
02
Drugs
sulindac
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01856322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01856322.